hvad så? Øjenafdelingen netværker via facebook - PDF Free Download
Gabor Liposits on Twitter: "Excellent presentation by @DrR_DUNNE on malnutrition at the Young SIOG poster walk. Great job by @MelissaLoh21 @rochgerionc Congratulations!! #YoungSIOG #SIOG2018… https://t.co/NA3go8hN8P"
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
Young SIOG Leadership | SIOG
Gabor Liposits (@G_LipositsMD) | Twitter
Stor indsats inden for onkologi og palliation blåstemples - Region Midtjylland
Tilbyr enda bedre kreftbehandling - rbnett.no - nyheter, sport, kultur og økonomi
Gabor Liposits (@G_LipositsMD) | Twitter
Loop | Zsolt Liposits
Gabor Liposits (@G_LipositsMD) | Twitter
Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @
Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective - Journal of Geriatric Oncology
Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit
Media Tweets by Gabor Liposits (@G_LipositsMD) | Twitter
Gabor LIPOSITS | PhD Student | University of Southern Denmark, Odense | SDU | Institute of Clinical Research
ESMOExaminationResults2015
Europæisk kræftorganisation udsteder særligt certifikat til Hospitalsenheden Vest
PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper